Wan Lee has 18 years’ experience in the hospital and pharmaceutical industry. At Pfizer Malaysia, she is responsible for leading and managing Pfizer’s Malaysia regulatory science team including developing regulatory strategies to support product registration, line extensions and lifecycle management.
In addition to managing her core responsibilities, she is also a member of the Pharmaceutical Association of Malaysia’s (PhAMA) Regulatory Core Team where she is proactively involved in regulatory policy. During the period 2021 to 2022, Wan Lee completed a successful part time secondment to Pfizer’s global regulatory policy & intelligence team.
She is a registered pharmacist and has a bachelor’s degree in pharmacy with honours from the University of Science, Malaysia and a Masters in Public Health from the University of Malaya, Malaysia. Wan Lee has published an article on Probability of Regulatory Success in Regulatory Focus which was selected as the finalist for Regulatory Affairs Professionals Society (RAPS) Article of the Year in 2021.
She has also published her work on “Access to Innovative Medicines: Regulation Change and Factors Associated with Drug Approval Lag in Malaysia” in the journal Therapeutic Innovation and Regulatory Science.
